Location
Australia, Oceania
Cheque size
$1M - $15M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Material Science
Food and Beverage
About Investor
Phil Morle is a Partner at Main Sequence, based in Sydney, Australia. He focuses on BioTech, Food and Beverage, and Material Science startups investing from Seed to Series A. Main Sequence typically invests between $1M and $15M, with an average investment of approximately $5M. He works closely with founders commercializing breakthrough scientific research into scalable businesses. Overall, he is a highly influential investor within Australia's deep science venture ecosystem.
Similar Investors
JF
Julie Fedele
Australia, Oceania
$5K - $5M
Pre Seed
,Seed
,MM
Melissa McBurnie
Australia, Oceania
$100K - $5M
Pre Seed
,Seed
,GM
Grant McCarthy
Australia, Oceania
$250K - $2.5M
Seed
,Series A
,DF
Dan Fitzgerald
Australia, Oceania
$250K - $5M
Seed
,NC
Nick Crocker
Australia, Oceania
$25K - $5M
Pre Seed
,Seed
,BB
Bill Bartee
Australia, Oceania
$250K - $20M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.